OTCYX
Price
$109.01
Change
-$2.22 (-2.00%)
Updated
Jul 13 closing price
Net Assets
6.28B
RGACX
Price
$82.84
Change
-$1.34 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

OTCYX vs RGACX

OTCYX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
OTCYX vs. RGACX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTCYX is a StrongBuy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 357B vs. OTCYX (6.28B). OTCYX (0.00) and RGACX (0.00) have matching dividends . OTCYX was incepted earlier than RGACX: OTCYX (29 years) vs RGACX (24 years). RGACX (0.93) is less costly to investors than OTCYX (0.70). OTCYX is a more actively managed with annual turnover of: 63.00 vs. RGACX (32.00). RGACX has a lower initial minimum investment than OTCYX: RGACX (250) vs OTCYX (1000). OTCYX annual gain was more profitable for investors over the last year : 7.70 vs. RGACX (3.68). OTCYX return over 5 years is better than : 17.63 vs. RGACX (13.46).
OTCYXRGACXOTCYX / RGACX
Total Expense Ratio0.700.9375%
Annual Report Gross Expense Ratio0.700.9375%
Fund Existence29 years24 years-
Gain YTD9.5546.959137%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets6.28B357B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.703.68209%
Returns for 3 years58.4537.13157%
Returns for 5 years17.6313.46131%
Returns for 10 years99.1497.58102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE0.660.02
+3.18%
VYNE Therapeutics
FRD34.510.25
+0.73%
Friedman Industries Inc
NUTX179.15-4.76
-2.59%
Nutex Health Inc.
HCA390.74-15.85
-3.90%
HCA Healthcare
KLIC106.49-6.92
-6.10%
Kulicke and Soffa Industries